The metabolic regulator histone deacetylase 9 contributes to glucose homeostasis abnormality induced by hepatitis C virus infection

Diabetes

Volumn 64, Issue 12, 2015, Pages 4088-4098

  Chen, Jizheng ^a   Wang, Ning ^b   Dong, Mei ^b   Guo, Min ^a   Zhao, Yang ^c   Zhuo, Zhiyong ^c   Zhang, Chao ^c   Chi, Xiumei ^d   Pan, Yu ^d   Jiang, Jing ^d   Tang, Hong ^a   Niu, Junqi ^d   Yang, Dongliang ^e   Li, Zhong ^b   Han, Xiao ^b   Wang, Qian ^b   Chen, Xinwen ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

^c INSTITUTE OF BIOPHYSICS   (China)

^d THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^e HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID; GLUCOSE; GLUCOSE 6 PHOSPHATASE; HISTONE DEACETYLASE 3; HISTONE DEACETYLASE 9; INSULIN; MESSENGER RNA; NONSTRUCTURAL PROTEIN 3; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SMALL INTERFERING RNA; TRANSCRIPTION FACTOR FKHR; TRICHOSTATIN A; CD81 ANTIGEN; CD81 PROTEIN, HUMAN; FORKHEAD TRANSCRIPTION FACTOR; FOXO1 PROTEIN, HUMAN; HDAC9 PROTEIN, HUMAN; HISTONE DEACETYLASE; OCCLUDIN; OCLN PROTEIN, HUMAN; PCK2 PROTEIN, HUMAN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); REPRESSOR PROTEIN; VIRUS RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL FRACTIONATION; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INDUCTION; FEMALE; GENETIC TRANSFECTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IN VITRO STUDY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER BIOPSY; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ACETYLATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REPLICON CELL; UBIQUITINATION; UPREGULATION; VIRUS LOAD; ACETYLATION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; CHRONIC HEPATITIS C; FINE NEEDLE ASPIRATION BIOPSY; GENETICS; LIVER; METABOLISM; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; RNA INTERFERENCE; TRANSGENIC MOUSE; TUMOR CELL LINE; VIROLOGY;

ACETYLATION; ANIMALS; ANTIGENS, CD81; BIOPSY, FINE-NEEDLE; CELL LINE, TUMOR; ENZYME INDUCTION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCONEOGENESIS; HEPATITIS C, CHRONIC; HISTONE DEACETYLASES; HUMANS; INSULIN RESISTANCE; LIVER; MALE; MICE, TRANSGENIC; OCCLUDIN; PHOSPHOENOLPYRUVATE CARBOXYKINASE (ATP); PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; REPRESSOR PROTEINS; RNA INTERFERENCE; RNA, VIRAL;

EID: 84962172862     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db15-0197     Document Type: Article

References (37)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345: 41-52
2. Magiorkinis G, Magiorkinis E, Paraskevis D, et al. The global spread of hepatitis C virus 1a and 1b: a phylodynamic and phylogeographic analysis. PLoS Med 2009;6:e1000198
3. Agnello V, De Rosa FG. Extrahepatic disease manifestations of HCV infection: some current issues. J Hepatol 2004;40:341-352
4. Lecube A, Hernández C, Genescà J, Simó R. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Diabetes Care 2006;29:1140-1149
5. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994;21:1135-1139
6. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008;49:831-844
7. Mason AL, Lau JY, Hoang N, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-333
8. Vanni E, Abate ML, Gentilcore E, et al. Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C. Hepatology 2009;50:697-706
9. Zhang W, Patil S, Chauhan B, et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem 2006;281:10105-10117
10. Puigserver P, Rhee J, Donovan J, et al. Insulin-regulated hepatic gluco-neogenesis through FOXO1-PGC-1alpha interaction. Nature 2003;423:550-555
11. Bernsmeier C, Calabrese D, Heim MH, Duong HT. Hepatitis C virus dysre-gulates glucose homeostasis by a dual mechanism involving induction of PGC1a and dephosphorylation of FoxO1. J Viral Hepat 2014;21:9-18
12. Deng L, Shoji I, Ogawa W, et al. Hepatitis C virus infection promotes hepatic gluconeogenesis through an NS5A-mediated, FoxO1-dependent pathway. J Virol 2011;85:8556-8568
13. Calnan DR, Brunet A. The FoxO code. Oncogene 2008;27:2276-2288
14. Yang XJ, Grégoire S. Class II histone deacetylases: from sequence to function, regulation, and clinical implication. Mol Cell Biol 2005;25:2873-2884
15. Sun Z, Miller RA, Patel RT, et al. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med 2012;18:934-942
16. Rodgers JT, Lerin C, Haas W, Gygi SP, Spiegelman BM, Puigserver P. Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 2005;434:113-118
17. Mihaylova MM, Vasquez DS, Ravnskjaer K, et al. Class IIa histone deace-tylases are hormone-activated regulators of FOXO and mammalian glucose ho-meostasis. Cell 2011;145:607-621
18. Pei R, Zhang X, Xu S, et al. Regulation of hepatitis C virus replication and gene expression by the MAPK-ERK pathway. Virol Sin 2012;27:278-285
19. Chen J, Zhao Y, Zhang C, et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res 2014;24:1050-1066
20. Han Q, Xu C, Wu C, Zhu W, Yang R, Chen X. Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus. Virus Res 2009;145:63-73
21. Wang Q, Chen J, Wang Y, Han X, Chen X. Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway. PLoS One 2012;7:e38522
22. She P, Shiota M, Shelton KD, Chalkley R, Postic C, Magnuson MA. Phos-phoenolpyruvate carboxykinase is necessary for the integration of hepatic energy metabolism. Mol Cell Biol 2000;20:6508-6517
23. Crapo PA, Kolterman OG, Henry RR. Metabolic consequence of two-week fructose feeding in diabetic subjects. Diabetes Care 1986;9:111-119
24. Fischle W, Dequiedt F, Hendzel MJ, et al. Enzymatic activity associated with class II HDACs is dependent on a multiprotein complex containing HDAC3 and SMRT/N-CoR. Mol Cell 2002;9:45-57
25. Banerjee A, Meyer K, Mazumdar B, Ray RB, Ray R. Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expression. J Virol 2010;84:5936-5946
26. Crunkhorn S. Metabolic disease: new role for HDACs in glucose homeo-stasis. Nat Rev Drug Discov 2011;10:492
27. de Zoeten EF, Wang L, Sai H, Dillmann WH, Hancock WW. Inhibition of HDAC9 increases T regulatory cell function and prevents colitis in mice. Gas-troenterology 2010;138:583-594
28. Chatterjee TK, Basford JE, Knoll E, et al. HDAC9 knockout mice are protected from adipose tissue dysfunction and systemic metabolic disease during high-fat feeding. Diabetes 2014;63:176-187
29. Vial G, Dubouchaud H, Couturier K, et al. Effects of a high-fat diet on energy metabolism and ROS production in rat liver. J Hepatol 2011;54:348-356
30. Matsuzawa-Nagata N, Takamura T, Ando H, et al. Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 2008;57:1071-1077
31. Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by b-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science 2013;339:211-214
32. Miura K, Taura K, Kodama Y, Schnabl B, Brenner DA. Hepatitis C virus-induced oxidative stress suppresses hepcidin expression through increased histone deacetylase activity. Hepatology 2008;48:1420-1429
33. Grozinger CM, Schreiber SL. Regulation of histone deacetylase 4 and 5 and transcriptional activity by 14-3-3-dependent cellular localization. Proc Natl Acad Sci U S A 2000;97:7835-7840
34. Nishino TG, Miyazaki M, Hoshino H, Miwa Y, Horinouchi S, Yoshida M. 14-3-3 regulates the nuclear import of class IIa histone deacetylases. Biochem Biophys Res Commun 2008;377:852-856
35. Qiang L, Banks AS, Accili D. Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. J Biol Chem 2010;285:27396-27401
36. Witt O, Deubzer HE, Milde T, Oehme I. HDAC family: what are the cancer relevant targets? Cancer Lett 2009;277:8-21
37. Walkinshaw DR, Yang XJ. Histone deacetylase inhibitors as novel anticancer therapeutics. Curr Oncol 2008;15:237-243